Parenteral-verapamil-induced sustained hypotension.

Area of Science:

• Cardiology
• Pharmacology

Background:

• Oral verapamil is generally considered safe regarding hypotension when combined with oral beta-adrenergic blockers.
• Intravenous verapamil administration has a major contraindication: recent (within 2 hours) intravenous beta-blocker use.

Observation:

• A case report details a patient who developed sustained hypotension following parenteral verapamil administration.
• This hypotension necessitated vasopressor support for approximately five hours.

Findings:

• The patient had a history of taking oral propranolol for five years.
• The last oral propranolol dose was taken approximately ten hours before receiving parenteral verapamil for supraventricular tachycardia.

Implications:

• This case highlights a potential risk of severe hypotension with parenteral verapamil, even when oral beta-blockers were taken more than 2 hours prior.
• It suggests a need for careful consideration of prior oral beta-blocker use when administering parenteral verapamil.
• Further investigation into the pharmacokinetics and pharmacodynamics of this drug interaction may be warranted.